Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $662.25M.
ENTERPRISE VALUE (EV)
$662.25M
MoonLake Immunotherapeutics
Market Cap
$921.06M
Enterprise Value (EV)
$662.25M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | $921.06M | $662.25M |
| CeriBell, Inc. (CBLL)vs › | $923.53M | $912.77M |
| HealthStream, Inc. (HSTM)vs › | $914.73M | $881.99M |
| Seaport Therapeutics, Inc. Common Stock (SPTX)vs › | $929.83M | $870.62M |
| Kura Oncology, Inc. (KURA)vs › | $934.79M | $889.01M |
| Savara Inc. (SVRA)vs › | $952.91M | $941.22M |
| Aktis Oncology, Inc. (AKTS)vs › | $953.81M | $882.56M |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $887.99M | $869.82M |
| Bioventus Inc. (BVS)vs › | $887.50M | $1.12B |
| Arbutus Biopharma Corp (ABUS)vs › | $884.97M | $869.42M |
Market Cap
$921.06M
Total Debt
$75.71M
Cash
$334.52M
Enterprise Value
$662.25M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
